1 |
Guo F, Chang CK, Fan HH et al (2008) Anti-tumour effects of exosomes in combination with cyclophosphamide and polyinosinic-polycytidylic acid. J Int Med Res 36, 1342-1353
DOI
|
2 |
Romagnoli GG, Zelante BB, Toniolo PA, Migliori IK and Barbuto JA (2014) Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets. Front Immunol 5, 692
DOI
|
3 |
Viaud S, Terme M, Flament C et al (2009) Dendritic cellderived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS One 4, e4942
DOI
|
4 |
Munich S, Sobo-Vujanovic A, Buchser WJ, Beer-Stolz D and Vujanovic NL (2012) Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands. Oncoimmunology 1, 1074-1083
DOI
|
5 |
Sobo-Vujanovic A, Munich S and Vujanovic NL (2014) Dendritic-cell exosomes cross-present Toll-like receptor-ligands and activate bystander dendritic cells. Cell Immunol 289, 119-127
DOI
|
6 |
Choo YW, Kang M, Kim HY et al (2018) M1 macrophage-derived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors. ACS Nano 12, 8977-8993
DOI
|
7 |
Escudier B, Dorval T, Chaput N et al (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med 3, 10
DOI
|
8 |
Zhang H, Xie Y, Li W, Chibbar R, Xiong S and Xiang J (2011) CD4(+) T cell-released exosomes inhibit CD8(+) cytotoxic T-lymphocyte responses and antitumor immunity. Cell Mol Immunol 8, 23-30
DOI
|
9 |
Xie Y, Zhang H, Li W et al (2010) Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity. J Immunol 185, 5268-5278
DOI
|
10 |
Zhu L, Kalimuthu S, Oh JM et al (2019) Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming. Biomaterials 190-191, 38-50
DOI
|
11 |
Derakhshani A, Vahidian F, Alihasanzadeh M, Mokhtarzadeh A, Lotfi Nezhad P and Baradaran B (2019) Mast cells: a double-edged sword in cancer. Immunol Lett 209, 28-35
DOI
|
12 |
Cheng L, Wang Y and Huang L (2017) Exosomes from M1-polarized macrophages potentiate the cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node. Mol Ther 25, 1665-1675
DOI
|
13 |
Wang P, Wang H, Huang Q et al (2019) Exosomes from M1-polarized macrophages enhance paclitaxel antitumor activity by activating macrophages-mediated inflammation. Theranostics 9, 1714-1727
DOI
|
14 |
Li Z, Suo B, Long G et al (2020) Exosomal miRNA-16-5p derived from M1 macrophages enhances T cell-dependent immune response by regulating PD-L1 in gastric cancer. Front Cell Dev Biol 8, 572689
DOI
|
15 |
Lin Y, Xu J and Lan H (2019) Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol 12, 76
DOI
|
16 |
Wu XQ, Dai Y, Yang Y et al (2016) Emerging role of microRNAs in regulating macrophage activation and polarization in immune response and inflammation. Immunology 148, 237-248
DOI
|
17 |
Farcas M and Inngjerdingen M (2020) Natural killer cellderived extracellular vesicles in cancer therapy. Scand J Immunol 92, e12938
DOI
|
18 |
Busatto S, Vilanilam G, Ticer T et al (2018) Tangential flow filtration for highly efficient concentration of extracellular vesicles from large volumes of fluid. Cells 7, 273
DOI
|
19 |
Mathieu M, Martin-Jaular L, Lavieu G and Thery C (2019) Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol 21, 9-17
DOI
|
20 |
Naslund TI, Gehrmann U, Qazi KR, Karlsson MC and Gabrielsson S (2013) Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity. J Immunol 190, 2712-2719
DOI
|
21 |
Segura E, Amigorena S and Thery C (2005) Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol Dis 35, 89-93
DOI
|
22 |
Morse MA, Garst J, Osada T et al (2005) A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med 3, 9
DOI
|
23 |
Lu J, Wu J, Xie F et al (2019) CD4(+) T cell-released extracellular vesicles potentiate the efficacy of the HBsAg vaccine by enhancing B cell responses. Adv Sci (Weinh) 6, 1802219
DOI
|
24 |
Kalluri R and LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367, eaau6977
DOI
|
25 |
Thery C, Zitvogel L and Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2, 569-579
DOI
|
26 |
Urbanelli L, Magini A, Buratta S et al (2013) Signaling pathways in exosomes biogenesis, secretion and fate. Genes (Basel) 4, 152-170
DOI
|
27 |
Peters PJ, Borst J, Oorschot V et al (1991) Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 173, 1099-1109
DOI
|
28 |
Li L, Jay SM, Wang Y, Wu SW and Xiao Z (2017) IL-12 stimulates CTLs to secrete exosomes capable of activating bystander CD8(+) T cells. Sci Rep 7, 13365
DOI
|
29 |
Seo N, Shirakura Y, Tahara Y et al (2018) Activated CD8(+) T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells. Nat Commun 9, 435
DOI
|
30 |
Cai Z, Yang F, Yu L et al (2012) Activated T cell exosomes promote tumor invasion via Fas signaling pathway. J Immunol 188, 5954-5961
DOI
|
31 |
Paolillo M and Schinelli S (2017) Integrins and exosomes, a dangerous liaison in cancer progression. Cancers (Basel) 9
|
32 |
Gao D and Jiang L (2018) Exosomes in cancer therapy: a novel experimental strategy. Am J Cancer Res 8, 2165-2175
|
33 |
Ngambenjawong C, Gustafson HH and Pun SH (2017) Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev 114, 206-221
DOI
|
34 |
Jong AY, Wu CH, Li J et al (2017) Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells. J Extracell Vesicles 6, 1294368
DOI
|
35 |
Zhu L, Kalimuthu S, Gangadaran P et al (2017) Exosomes derived from natural killer cells exert therapeutic effect in melanoma. Theranostics 7, 2732-2745
DOI
|
36 |
Neviani P, Wise PM, Murtadha M et al (2019) Natural killer-derived exosomal miR-186 inhibits neuroblastoma growth and immune escape mechanisms. Cancer Res 79, 1151-1164
DOI
|
37 |
Bernsmeier C, van der Merwe S and Perianin A (2020) Innate immune cells in cirrhosis. J Hepatol 73, 186-201
DOI
|
38 |
Kibria G, Ramos EK, Wan Y, Gius DR and Liu H (2018) Exosomes as a drug delivery system in cancer therapy: potential and challenges. Mol Pharm 15, 3625-3633
DOI
|
39 |
Segura E, Guerin C, Hogg N, Amigorena S and Thery C (2007) CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol 179, 1489-1496
DOI
|
40 |
Batrakova EV and Kim MS (2015) Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release 219, 396-405
DOI
|
41 |
Li Y, Wan YY and Zhu B (2017) Immune cell metabolism in tumor microenvironment. Adv Exp Med Biol 1011, 163-196
DOI
|
42 |
Guo S and Deng CX (2018) Effect of stromal cells in tumor microenvironment on metastasis initiation. Int J Biol Sci 14, 2083-2093
DOI
|
43 |
Steinman RM (2012) Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 30, 1-22
DOI
|
44 |
McLellan AD (2009) Exosome release by primary B cells. Crit Rev Immunol 29, 203-217
DOI
|
45 |
Guan S, Li Q, Liu P, Xuan X and Du Y (2014) Umbilical cord blood-derived dendritic cells loaded with BGC823 tumor antigens and DC-derived exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumor immunity in vitro and in vivo. Cent Eur J Immunol 39, 142-151
|
46 |
Lugini L, Cecchetti S, Huber V et al (2012) Immune surveillance properties of human NK cell-derived exosomes. J Immunol 189, 2833-2842
DOI
|
47 |
Nolte-'t Hoen EN, Buschow SI, Anderton SM, Stoorvogel W and Wauben MH (2009) Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood 113, 1977-1981
DOI
|
48 |
Lu Z, Zuo B, Jing R et al (2017) Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models. J Hepatol 67, 739-748
DOI
|
49 |
Yong T, Zhang X, Bie N et al (2019) Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nat Commun 10, 3838
DOI
|
50 |
Matsumoto K, Morisaki T, Kuroki H et al (2004) Exosomes secreted from monocyte-derived dendritic cells support in vitro naive CD4+ T cell survival through NF-(kappa)B activation. Cell Immunol 231, 20-29
DOI
|
51 |
Besse B, Charrier M, Lapierre V et al (2016) Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology 5, e1071008
DOI
|
52 |
Simhadri VR, Reiners KS, Hansen HP et al (2008) Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. PLoS One 3, e3377
DOI
|
53 |
Wang J, Wang Z, Mo Y, Zeng Z, Wei P and Li T (2015) Effect of hyperthermic CO2-treated dendritic cell-derived exosomes on the human gastric cancer AGS cell line. Oncol Lett 10, 71-76
DOI
|
54 |
Wahlgren J, Karlson Tde L, Glader P, Telemo E and Valadi H (2012) Activated human T cells secrete exosomes that participate in IL-2 mediated immune response signaling. PLoS One 7, e49723
DOI
|
55 |
Bebelman MP, Smit MJ, Pegtel DM and Baglio SR (2018) Biogenesis and function of extracellular vesicles in cancer. Pharmacol Ther 188, 1-11
DOI
|
56 |
Min H, Sun X, Yang X et al (2018) Exosomes derived from irradiated esophageal carcinoma-infiltrating T cells promote metastasis by inducing the epithelial-mesenchymal transition in esophageal cancer cells. Pathol Oncol Res 24, 11-18
DOI
|
57 |
Santos P and Almeida F (2021) Exosome-based vaccines: history, current state, and clinical trials. Front Immunol 12, 711565
DOI
|
58 |
Pitt JM, Charrier M, Viaud S et al (2014) Dendritic cell-derived exosomes as immunotherapies in the fight against cancer. J Immunol 193, 1006-1011
DOI
|
59 |
Chen DS and Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39, 1-10
DOI
|
60 |
Saxena M, van der Burg SH, Melief CJM and Bhardwaj N (2021) Therapeutic cancer vaccines. Nat Rev Cancer 21, 360-378
DOI
|
61 |
Zitvogel L, Regnault A, Lozier A et al (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 4, 594-600
DOI
|
62 |
Andre F, Chaput N, Schartz NE et al (2004) Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol 172, 2126-2136
DOI
|
63 |
Pitt JM, Andre F, Amigorena S et al (2016) Dendritic cell-derived exosomes for cancer therapy. J Clin Invest 126, 1224-1232
DOI
|
64 |
Qazi KR, Gehrmann U, Domange Jordo E, Karlsson MC and Gabrielsson S (2009) Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism. Blood 113, 2673-2683
DOI
|
65 |
Segura E, Nicco C, Lombard B et al (2005) ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 106, 216-223
DOI
|
66 |
Kalluri R (2016) The biology and function of exosomes in cancer. J Clin Invest 126, 1208-1215
DOI
|
67 |
Ciardiello C, Cavallini L, Spinelli C et al (2016) Focus on extracellular vesicles: new frontiers of cell-to-cell communication in cancer. Int J Mol Sci 17, 175
DOI
|
68 |
Fu W, Lei C, Liu S et al (2019) CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity. Nat Commun 10, 4355
DOI
|
69 |
Thery C, Witwer KW, Aikawa E et al (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV 2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7, 1535750
DOI
|
70 |
Kahlert C and Kalluri R (2013) Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) 91, 431-437
DOI
|
71 |
van Niel G, D'Angelo G and Raposo G (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19, 213-228
DOI
|
72 |
Thery C, Duban L, Segura E, Veron P, Lantz O and Amigorena S (2002) Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol 3, 1156-1162
DOI
|
73 |
Wei G, Jie Y, Haibo L et al (2017) Dendritic cells derived exosomes migration to spleen and induction of inflammation are regulated by CCR7. Sci Rep 7, 42996
DOI
|